Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Nilotinib)Therapy

NCT01490775 is registered in ClinicalTrials.gov with Rex Cancer Center, Raleigh, NC as lead sponsor.

NCT NCT01490775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Nilotinib)Therapy
Lead sponsor
Rex Cancer Center, Raleigh, NC
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2009
Completion date
June 30, 2015
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic phase cml